The pathogenic mechanisms of Shiga toxin and the Shiga-like toxins.
about
Diarrheagenic Escherichia coliPathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infectionsBacterial toxins: friends or foes?Induction by sphingomyelinase of shiga toxin receptor and shiga toxin 2 sensitivity in human microvascular endothelial cells.Rapid apoptosis induced by Shiga toxin in HeLa cells.Enteric bacterial toxins: mechanisms of action and linkage to intestinal secretion.Essential role for verotoxin in sustained stress-activated protein kinase and nuclear factor kappa B signaling, stimulated by Escherichia coli O157:H7 in Vero cells.Characterization of Shiga toxin-producing Escherichia coli O157:H7 isolated in Italy and in France.Multiplex PCR for diagnosis of enteric infections associated with diarrheagenic Escherichia coliProtection against Shiga toxin-producing Escherichia coli infection by transcutaneous immunization with Shiga toxin subunit BThe A1 Subunit of Shiga Toxin 2 Has Higher Affinity for Ribosomes and Higher Catalytic Activity than the A1 Subunit of Shiga Toxin 1.Shiga toxin-associated hemolytic uremic syndrome: interleukin-1 beta enhancement of Shiga toxin cytotoxicity toward human vascular endothelial cells in vitroSecretion of extracellular proteins by enterohemorrhagic Escherichia coli via a putative type III secretion system.Structure and function of plasmid pColD157 of enterohemorrhagic Escherichia coli O157 and its distribution among strains from patients with diarrhea and hemolytic-uremic syndrome.Comparison of the relative toxicities of Shiga-like toxins type I and type II for miceVirulence of enterohemorrhagic Escherichia coli O91:H21 clinical isolates in an orally infected mouse modelDifferences in Ribosome Binding and Sarcin/Ricin Loop Depurination by Shiga and Ricin HolotoxinsIsolation and characterization of verocytotoxin-producing Escherichia coli O157 strains from Dutch cattle and sheep.Occurrence of verocytotoxin-producing Escherichia coli O157 on Dutch dairy farmsDisruption of an internal membrane-spanning region in Shiga toxin 1 reduces cytotoxicity.Salmonella enterica serovar Typhimurium vaccine strains expressing a nontoxic Shiga-like toxin 2 derivative induce partial protective immunity to the toxin expressed by enterohemorrhagic Escherichia coli.Comparison of binding platforms yields insights into receptor binding differences between shiga toxins 1 and 2Global expression of prophage genes in Escherichia coli O157:H7 strain EDL933 in response to norfloxacin.Diarrheagenic Escherichia coli in children from Costa Rica.One of two copies of the gene for the activatable shiga toxin type 2d in Escherichia coli O91:H21 strain B2F1 is associated with an inducible bacteriophageShiga toxin binding to glycolipids and glycans.Clinical isolates of Shiga toxin 1a-producing Shigella flexneri with an epidemiological link to recent travel to Hispañiola.Purified Shiga-like toxins induce expression of proinflammatory cytokines from murine peritoneal macrophages.Expression of putative virulence factors of Escherichia coli O157:H7 differs in bovine and human infectionsShiga-like toxin II impairs hepatobiliary transport of doxorubicin in rats by down-regulation of hepatic P glycoprotein and multidrug resistance-associated protein Mrp2Transmission of Escherichia coli O157:H7 in cattle is influenced by the level of environmental contamination.Verotoxin activates mitogen-activated protein kinase in human peripheral blood monocytes: role in apoptosis and proinflammatory cytokine release.Bovine immune response to shiga-toxigenic Escherichia coli O157:H7Enterohemorrhagic Escherichia coli O157:H7 requires intimin to colonize the gnotobiotic pig intestine and to adhere to HEp-2 cells.Activation of Shiga-like toxins by mouse and human intestinal mucus correlates with virulence of enterohemorrhagic Escherichia coli O91:H21 isolates in orally infected, streptomycin-treated mice.Truncated enterohemorrhagic Escherichia coli (EHEC) O157:H7 intimin (EaeA) fusion proteins promote adherence of EHEC strains to HEp-2 cells.Coexpression of the B subunit of Shiga toxin 1 and EaeA from enterohemorrhagic Escherichia coli in Vibrio cholerae vaccine strainsImplication of virulence factors in Escherichia coil O157:H7 pathogenesis.Two distinct cytotoxic activities of subtilase cytotoxin produced by shiga-toxigenic Escherichia coli.Impact of Infection Dose and Previous Serum Antibodies against the Locus of Enterocyte Effacement Proteins on Escherichia coli O157:H7 Shedding in Calves following Experimental Infection.
P2860
Q24533466-D93566EE-5A6F-4A98-AE9C-837DFC803DEEQ24550740-6CE183E1-C43C-426B-B0C2-ACE00BEB9B31Q24653980-58EA160D-393C-4F73-B2A5-8F4962133087Q30310446-57B7F45F-487B-4FF3-A665-444D47CDDB7BQ30310781-425B6691-19D2-4A64-B9DE-7D448FF98F52Q30449794-72C66307-3D79-4227-9A0E-91CB47C3351EQ30453237-675C9163-7509-4F98-8DC1-7355E9C34437Q33345478-7E757EC3-E072-40AE-B185-91977B385E41Q33360323-FE6D81D8-2A29-4AB9-9C3E-4412B05673ABQ33377371-7C21B078-C7F5-4139-9859-13EE9B1705C4Q33426867-457FCE1E-EB34-41A8-8CAB-B6DF65CA3383Q33493841-83D0EA54-A78E-45A9-8E7C-7F0C4C274E09Q33497474-81C49C98-1C2D-4310-9D07-1CF2B254ADC6Q33501374-546B3E27-489C-45F8-B6C5-3F0341399231Q33605233-F3347FA9-A5B0-4DA3-97DF-FC32ADE3058EQ33608157-7C491A97-1B01-442A-B3D2-0E11571260E6Q33612042-08046654-AF26-4C9A-A5FA-A7DA157BC363Q33661058-740FA39F-D9F5-4865-9F6B-0C7EEEDC54CCQ33684744-9245E4DA-59A4-4637-BBB6-07ED7CE1D0FCQ33767533-3F724C77-73E5-4ABB-A30A-12DFAD77A2BAQ33768681-0EE75255-B8D1-42AF-97D6-510DF47C7A9CQ33801217-8999FEB5-5B90-4045-8125-51E24E7CF2B8Q33856818-8A681517-3D7C-4726-AFBF-195B62C77B23Q34024807-5A138EFC-82FD-4BFF-8576-87C3926032ABQ34128036-7DA47F72-A7D0-40A9-B6E6-67E600877118Q34163196-DFD171EF-0506-42E9-BF9F-C248893AD1E5Q34320438-5689B1FC-4D42-472B-A12C-ACCC09097A68Q34545284-AFDB472C-EFD4-4503-B301-1C106E5B663EQ34720964-CF2B5E48-BCCD-44DF-87FB-AB584A01D980Q34938668-24961981-79DB-40B4-900E-697BA0AC2188Q34992943-2C097F1B-8B0B-4016-BEBD-519D1C3C6D38Q35045942-976EA587-00B0-4333-9B5C-A582B56D79A4Q35216120-A03CC931-08C0-41C8-9DD8-62688ECFCFCEQ35440445-99D6C627-D9D5-4DF2-82EF-089509C5D0FEQ35487599-B08C7AC8-5C05-4272-9BEF-D904499072B5Q35499213-0C1AF499-390F-4062-89AD-E76A384D5030Q35548775-5D1F74BF-FEE2-4270-B0A9-0BC71EE6C67FQ35592357-7C8BFF78-9779-4937-A6A4-BAB2778872ADQ35689027-26AD1F94-7B61-44F1-883E-D6435F8A74C8Q35763722-0E987859-2FF9-4A6A-93B5-F1F45C558306
P2860
The pathogenic mechanisms of Shiga toxin and the Shiga-like toxins.
description
1991 nî lūn-bûn
@nan
1991 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
The pathogenic mechanisms of Shiga toxin and the Shiga-like toxins.
@ast
The pathogenic mechanisms of Shiga toxin and the Shiga-like toxins.
@en
type
label
The pathogenic mechanisms of Shiga toxin and the Shiga-like toxins.
@ast
The pathogenic mechanisms of Shiga toxin and the Shiga-like toxins.
@en
prefLabel
The pathogenic mechanisms of Shiga toxin and the Shiga-like toxins.
@ast
The pathogenic mechanisms of Shiga toxin and the Shiga-like toxins.
@en
P2860
P1476
The pathogenic mechanisms of Shiga toxin and the Shiga-like toxins.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2958.1991.TB00805.X
P407
P577
1991-08-01T00:00:00Z